Hospital-Based Contingency Management

NCT05515757 | Enrolling By Invitation

• 1 other identifier: STUDY00023484
• Study Type: interventional
• Target: 90
• Locations: 1 country
• Sites: 1

Brief Summary

This study aims to adapt an outpatient mobile app-based contingency management intervention to the hospital setting to understand how we can use contingency management to improve health outcomes in hospitalized patients with stimulant use disorders.

Conditions

Amphetamine-Related Disorders

Keywords

Amphetamine-Related Disorders; substance-related disorders; behavior therapy; psychology reinforcement; hospital medicine

Outcome Measures

Primary Outcomes (1)

• Intervention acceptability and feasibility

  Evaluated using semi-structured qualitative interviews with participants and staff

  Week 0-8

Secondary Outcomes (3)

• Brief Addiction Monitor (BAM)

  Week 0-8

• Participant engagement in the contingency management intervention

  Week 0-8

• Participant drug test results

  Week 0-8

Study Arms (1)

Mobile app-based contingency management

OTHER

All participants will be enrolled into an 8-week mobile app-based contingency management intervention starting during a prolonged hospitalization.

Behavioral: Mobile-app based contingency management

Interventions

Mobile-app based contingency management BEHAVIORAL

We are adapting an evidence-based outpatient mobile-app based CM intervention to the hospital setting for hospitalized patients with stimulant use disorders requiring prolonged hospitalization. Participants will be enrolled into an 8-week mobile-app based contingency management intervention.

Mobile app-based contingency management

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Be 18 years of age or older
• Have moderate to severe stimulant use disorder, as diagnosed using DSM-5 criteria for stimulant use disorder by an addiction medicine provider
• Have an anticipated hospital length of stay greater than 2 weeks
• Be able to use a smartphone and agree to download and use the Affect app as part of study-related procedures
• Be English speaking and be able to understand explanations of study procedures and the informed consent to participate

You may not qualify if:

• Unable to engage in the intervention due to cognitive impairment or altered mental status
• Unable to engage in the intervention due to acute medical/mental health issues, per judgement of the research assistant

Sponsors & Collaborators

• Oregon Health and Science University: lead
• CareOregon: collaborator
• Affect Therapeutics, Inc.: collaborator

Study Sites (1)

Linda Peng

Portland, Oregon, 97239, United States

Location

Related Publications (1)

• Peng L, Young K, Titus H, Peeples J, Song E, DeFrancesco C, Roellich P, Phillips R, Englander H. Supporting Patients With Stimulant Use Disorder During and After Hospitalization With a Mobile App-based Contingency Management Intervention: A Feasibility and Acceptability Study. J Addict Med. 2025 Nov 25. doi: 10.1097/ADM.0000000000001621. Online ahead of print.

  PMID: 41287143 DERIVED

MeSH Terms

Conditions

Amphetamine-Related Disorders; Substance-Related Disorders

Condition Hierarchy (Ancestors)

Chemically-Induced Disorders; Mental Disorders

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: TREATMENT
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Principal Investigator

Study Record Dates

• First Submitted: August 10, 2022
• First Posted: August 25, 2022
• Study Start: August 22, 2022
• Primary Completion: December 1, 2024
• Study Completion: December 1, 2024
• Last Updated: May 8, 2024

Record last verified: 2024-05

Data Sharing

• IPD Sharing: Will not share

Locations

US (1)